Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 29;7(1):214.
doi: 10.1186/s13643-018-0884-5.

Quantified patient preferences for lifestyle intervention programs for diabetes prevention-a protocol for a systematic review

Affiliations

Quantified patient preferences for lifestyle intervention programs for diabetes prevention-a protocol for a systematic review

Charalabos-Markos Dintsios et al. Syst Rev. .

Abstract

Background: The 20-70% participation of diabetes patients in lifestyle interventions (LSI) worldwide seems to be rather sub-optimal, in spite of all intents of such interventions to delay further progress of the disease. Positive effects through LSI are expected in particular for patients who suffer less from diabetes-related limitations or other chronic diseases. Seeing that diabetes prevalence and with it mortality are increasing, LSI have become an inherent part of diabetes treatment standards. Various qualitative studies have been carried out to identify participation barriers for LSI. However, these have not resulted in more detailed knowledge about the relative importance of factors with an inhibiting impact on participation. Since it cannot be assumed that all of the influencing factors have equivalent values, it is necessary to investigate their individual importance with regard to a positive or negative decision about participating. There are no systematic reviews on patient preferences for LSI programs in diabetes prevention. As a result, the main objectives of this systematic review are to (i) identify existing patient preference elicitation studies related to LSI for diabetic patients, (ii) summarize the methods applied and findings, and (iii) appraise the reporting and methodological quality of such studies.

Methods: We will perform systematic literature searches to identify suitable studies from 14 electronic databases. Retrieved study records will be included based on predefined eligibility criteria as defined in this protocol. We will run abstract and full-text screenings and then extract data from all selected studies by filling in a predefined data extraction spreadsheet. We will undertake a descriptive, narrative synthesis of findings to address the study objectives, since no pooling for quantified preferences is for methodological reasons implementable. We will pay special attention to aspects of methodological quality of preference elicitation by applying established evaluation criteria of the ISPOR and some own developed criteria for different elicitation techniques. All critical stages within the screening, data extraction, and synthesis processes will be conducted by two pairs of authors. This protocol adheres to PRISMA and PRISMA-P standards.

Discussion: The proposed systematic review will provide an overview of the methods used and current practice in the elicitation and quantification of patients' preferences for diabetes prevention lifestyle interventions. Furthermore, the methodological quality of the identified studies will be appraised as well.

Systematic review registration: PROSPERO CRD42018086988.

Keywords: Analytic hierarchy process; Conjoint analysis; Diabetes mellitus; Discrete choice analysis; Multi-criteria decision analysis; Patient preferences; Preference elicitation; Preferences weights; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Authors’ information

CMD is, next to his industrial affiliation, a visiting researcher at the Institute for Health Services Research and Health Economics at the Heinrich-Heine-University, Düsseldorf, Germany. NC is a senior researcher at the Institute for Health Services Research and Health Economics at the Heinrich-Heine-University, Düsseldorf, Germany. BG is a cooperating psychologist at the Institute for Health Services Research and Health Economics at the Heinrich-Heine-University, Düsseldorf, Germany. AI is the head of the Institute for Health Services Research and Health Economics at the German Diabetes Centre in Düsseldorf and the head of the Institute for Health Services Research and Health Economics at the Heinrich- Heine-University, Düsseldorf, Germany.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Next to his academic affiliation, CMD is employed by Bayer Vital GmbH, Leverkusen, Germany. All other authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Similar articles

Cited by

References

    1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet (London, England) 2011;378(9785):31–40. doi: 10.1016/S0140-6736(11)60679-X. - DOI - PubMed
    1. International Diabetes Federation . IDF diabetes atlas. 8. Brussels: International Diabetes Federation; 2017. - PubMed
    1. Icks A, Haastert B, Gandjour A, Chernyak N, Rathmann W, Giani G, Rump LC, Trapp R, Koch M. Costs of dialysis--a regional population-based analysis. Nephrol Dial Transplant. 2010;25(5):1647–1652. doi: 10.1093/ndt/gfp672. - DOI - PubMed
    1. Icks A, Scheer M, Morbach S, Genz J, Haastert B, Giani G, Glaeske G, Hoffmann F. Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: survival in a population-based 5-year cohort in Germany. Diabetes Care. 2011;34(6):1350–1354. doi: 10.2337/dc10-2341. - DOI - PMC - PubMed
    1. Icks A, Claessen H, Morbach S, Glaeske G, Hoffmann F. Time-dependent impact of diabetes on mortality in patients with stroke: survival up to 5 years in a health insurance population cohort in Germany. Diabetes Care. 2012;35(9):1868–1875. doi: 10.2337/dc11-2159. - DOI - PMC - PubMed